Login to Your Account



Eisai Partnership a Ringing Endorsement of EZH2

By Catherine Shaffer


Friday, March 11, 2011

Epizyme Inc. views its potential $206 million new partnership agreement with Eisai Co. Ltd. as an endorsement of its research and development efforts in EZH2, and as a complement to its recent deal with GlaxoSmithKline plc within its overall business strategy.

BioWorld Today Contributing Writer

Epizyme Inc. views its potential $206 million new partnership agreement with Eisai Co. Ltd.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription